Clinical Trial Update: Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

View source ↗

Summary

Compassionate-use clinical trial update evaluating NHWD-870 in patients with NUT rearrangement–positive cancers, specifically NUT midline carcinoma, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nut Midline Carcinoma

Drugs mentioned

• NHWD-870

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Advanced Solid Tumors or Lymphomas | Status: RECRUITING